EU Medicines Agency @EMA_News@respublicae.eu
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.
Joined Apr 2022
RT @EU_Health: Civil society organisations make an invaluable contribution to health policy making and are key for building a strong European #HealthUnion
RT @EU_Health: Let's discuss early detection of cancer:
On 29 September, join the #RiDaysEU on a session on how to better integrate research and innovation in cancer screening programmes.
Agenda details & registration:
https://ec.europa.eu/research-and-innovation/en/events/upcoming-events/research-innovation-days
Today is EMA’s first in-person workshop since #COVID19!
We’re discussing methodologies to enhance the use of #patients’ experience in the development of 💊and regulatory decision-making.
Recording available soon:
👉https://www.ema.europa.eu/en/events/multi-stakeholder-workshop-patient-experience-data-medicines-development-regulatory-decision-making
#EMApatientexperience
RT @EU_opendata: Episode 5 of 🏆 #EUDatathon's ‘The Teams behind the apps’ 🎬 is out!
Meet today the Lobium/Gavagai team from 🇳🇱 🇸🇪 🇬🇧! Proposed for the #DigitalEU challenge, their app will help journalists scrutinise proposals for #EULaw. See the clip then read more ▶https://data.europa.eu/en/news/eu-datathon-2022-teams-behind-apps-meet-lobiumgavagai?pk_campaign=TeamVideoSeries&pk_medium=tw
RT @EU_Health: The new EU recommendations on cancer screening include:
🔸Extending access to targeted cancer screening for breast, colorectal & cervical cancers
🔸A step-by-step approach to introducing prostate, lung & gastric cancer testing
Factsheet: https://ec.europa.eu/commission/presscorner/detail/en/fs_22_5586
‼️ EMA is holding a regular press briefing on #COVID19 and #monkeypox. It will be broadcast live 🔴 today, 20 September, from 15:30 to 16:00 CET. #EMAPresser
👉https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-monkeypox-0
RT @EU_Health: The new EU recommendations on cancer screening include:
🔸Extending access to targeted cancer screening for breast, colorectal & cervical cancers
🔸A step-by-step approach to introducing prostate, lung & gastric cancer testing
Factsheet: https://ec.europa.eu/commission/presscorner/detail/en/fs_22_5586
RT @EU_Health: Early cancer detection can save lives.
Yet, coverage of the target population ranges from 6- 90% for breast cancer screening and from 25-80% for cervical cancer screening. This needs to change.
See our Q&A's on cancer screening:
https://ec.europa.eu/commission/presscorner/detail/en/qanda_22_5584
RT @SKyriakidesEU: It is estimated that one in two 🇪🇺 🧑🏽🤝🧑🏻 will develop cancer during their lifetime. To change this trend, we need to screen more and better.
Today, we mark a turning point for EU cancer screening with a new Recommendation based on the most recent scientific evidence.
#EUCancerPlan
RT @EU_Health: The #EU4Health Programme can help us build back better from the COVID-19 pandemic.
We have launched a new call for proposals to support for public procurement in the health sector & crises preparedness ⬇ ⬇ ⬇
RT @EU_Health: Early cancer detection can save lives.
Today we are proposing a new EU approach to cancer screening based on the latest science & technology.
Join Commissioner @SKyriakidesEU live from +/- 12.30pm:
📺https://audiovisual.ec.europa.eu/en/ebs/live/1
🆕 EU-approved 🇪🇺 #biosimilar #medicines are interchangeable with their reference medicine or an equivalent biosimilar 💊💉
Biosimilar medicines provide #patients with more therapeutic options to treat serious diseases such as #cancer and #diabetes.
👉 https://www.ema.europa.eu/en/news/biosimilar-medicines-can-be-interchanged
📢EMA's human medicines committee, the #CHMP, recommends 12 new #medicines for approval in the 🇪🇺, including treatments against:
☑️lower respiratory tract disease in babies
☑️haemolytic anaemia
☑️cancer
☑️osteoporosis
☑️insomnia
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-september-2022
#PublicHealth 🧵
#COVID19vaccines: Where are we now?
6⃣ authorisations completed
3⃣ #AdaptedVaccines targeting Omicron subvariants approved
RT @EU_HaDEA: Closing soon!
Apply to the #EU4Health call for #tenders to support competent authorities in Substances of Human Origins (#SoHO) with #training and networking activities
🗓️ Deadline: 20 September
💶€ 2M
RT @SKyriakidesEU: Now more than ever we must take better care of each other and our mental health.
As announced by @vonderleyen next year we present a new comprehensive approach on mental health.
For those who feel anxious and lost, accessible, affordable support can make the difference.
#SOTEU
RT @EC_HERA: It seems like only yesterday…#SOTEU 2021 promised a functioning HERA.
#HERA continues to protect our citizens, from #COVID19 to #Monkeypox, with vaccines and therapeutics.
What a difference a year makes 💪🎉
RT @EU_Commission: The pandemic was a turning point for our Union. And we overcame it with unity and solidarity.
Thanks to the EU vaccine strategy, 83.4% of the EU adult population has received primary vaccination against COVID-19, saving thousands of lives.
RT @EU_Commission: All EU countries must be equally prepared and react in case of future outbreaks.
This is why we laid the foundations of a European Health Union through:
🔹 the new Health Emergency Preparedness and Response Authority
🔸 a proposal for a European Health Data Space
#SOTEU
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.
Joined Apr 2022
